Тематические порталы ИД "Русский врач": Кардиология, Педиатрия
 
     


Конкурсы и гранты
 

Тревожные расстройства и беременность
Автор: Ушкалова А., Ушкалова Е.   

 

magazine-vrach-2013-04-003

Тревожные расстройства и беременность

В статье описываются эпидемиология, течение тревожных расстройств во время беременности, их влияние на исход для матери и плода, особенности фармакотерапии и потенциальные негативные эффекты лекарственных средств на плод/новорожденного.
Anxiety disorders and pregnancy
The paper describes the epidemiology and the course of anxiety disorders during pregnancy, their impact on maternal and fetal outcomes, the specific features of pharmacotherapy, and the potential negative effects of drugs on the fetus/ newborn infant.
Литература

 

  1. Kitamura T., Yoshida K., Okano T. et al. Multicentre prospective study of perinatal depression in Japan: incidence and correlates of antenatal and postnatal depression // Arch. Wom. Ment Health. – 2006; 9 (3): 121–30.

  2. Heron J., O'Connor T., Evans J. et al. The course of anxiety and depression through pregnancy and the postpartum in a community sample // J. Affect. Dis. – 2004; 80 (1): 65–73.

  3. Li D., Liu L., Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: a prospective cohort study // Hum. Reprod. – 2009; 24 (1): 146–53.

  4. O'Connor T., Heron J., Glover V. Antenatal anxiety predicts child behavioral/emotional problems independently of postnatal depression // J. Am. Acad. Child & Adolesc. Psychiat. – 2002; 41 (12): 1470–7.

  5. Nasreen H., Kabir Z., Forsell Y. et al. Prevalence and associated factors of depressive and anxiety symptoms during pregnancy: A population based study in rural Bangladesh // BMC Womens Health. – 2011; 11 (1): 22.

  6. Vesga-Lopez O., Blanco C., Keyes K. et al. Psychiatric disorders in pregnant and postpartum women in the United States // Arch. Gen. Psychiatry. – 2008; 65: 805–15.

  7. Аведисова А.С. Депрессия + тревога: диагностика и лечение. М., 2003; 52.

  8. Canadian Psychiatric Association. Clinical practice guidelines. Management of anxiety disorders // Can. J. Psychiat. – 2006; 51 (8 Suppl. 2): 9S–91S.

  9. Lee A., Lam S., Sze M. et al. Prevalence, Course, and Risk Factors for Antenatal Anxiety and Depression // Obstet. Gynecol. – 2007; 5 (110): 1102–12.

  10. Ross L., McLean L. Anxiety disorders during pregnancy and the postpartum period: A systematic review // J. Clin. Psychiat. – 2006; 67 (8): 1285–98.

  11. Wenzel A., Haugen E., Jackson L. et al. Prevalence of generalized anxiety at eight weeks postpartum // Arch. Women's Mental Health. – 2003; 6 (1): 43–9.

  12. Eros E., Hajós A. Prevention of perinatal depression and anxiety with periconceptional care // Orv. Hetil. – 2011; 152 (23): 903–8.

  13. Wisner K., Peindl K., Hanusa B. Effects of childbearing on the natural history of panic disorder with comorbid mood disorder // J. Affect. Dis. – 1996; 41: 173–80.

  14. Yonkers K., Vigod S., Ross L. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women // Obst. Gynecol. – 2011; 117 (4): 961–7.

  15. Gold K., Marcus S. Effect of Maternal Mental Illness on Pregnancy Outcomes // Exp. Rev. Obst. Gynecol. – 2008; 3 (3): 391–401.

  16. Buist A., Gotman N., Yonkers K. Generalized Anxiety Disorder: Course and Risk Factors in Pregnancy // J. Affect. Dis. – 2011; 131 (1–3): 277–83.

  17. Robling S., Paykel E., Dunn V. et al. Long-term outcome of severe puerperal psychiatric illness: a 23 year follow-up study // Psychol. Med. – 2000; 30, 1263–71.

  18. Cohen L., Goldstein J., Grush L. Impact of pregnancy on risk for relapse of major depressive disorder. Paper presented at the American Psychiatric Association Annual meeting. New York, 1996.

  19. De Pender A., Lambregtse-van den Berg M., Raats M. Obsessive compulsive disorder during pregnancy and the postpartum period // Tijdschr. Psychiatr. – 2012; 54 (6): 549–53.

  20. Sie S., Wennink J., van Driel J. et al. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation // Arch. Dis. Child Fetal. Neonatal. Ed. – 2012; 97 (6): F472–6.

  21. Uguz F., Kaya V., Gezginc K. et al. Clinical correlates of worsening in obsessive-compulsive symptoms during pregnancy // Gen Hosp Psychiatry. – 2011; 33 (2): 197–9.

  22. Zambaldi C., Cantilino A., Montenegro A. et al. Postpartum obsessive-compulsive disorder: prevalence and clinical characteristics // Compr. Psychiatry. – 2009; 50 (6): 503–9.

  23. Uguz F., Gezginc K., Kayhan F. et al. Is hyperemesis gravidarum associated with mood, anxiety and personality disorders: a case-control study // Gen. Hosp. Psychiatry. – 2012; 34 (4): 398–402.

  24. Uguz F., Gezginc K., Zeytinci I. et al. Obsessive-compulsive disorder in pregnant women during the third trimester of pregnancy // Compr. Psychiatry. – 2007; 48 (5): 441–532.

  25. Sichel D., Cohen L., Dimmock J. et al. Postpartum obsessive compulsive disorder: a case series // J. Clin. Psychiatry. – 1993; 54: 156–9.

  26. Rosso G., Bechon E., Bogetto F. et al. OCD during pregnancy and post partum // Riv. Psichiatr. – 2012; 47 (3): 200–4.

  27. Sichel D., Cohen L., Rosenbaum J. et al. Postpartum onset of obsessive-compulsive disorder // Psychosomatics. – 1993; 34: 277–9.

  28. McGuinness M., Blissett J., Jones C. OCD in the perinatal period: is postpartum OCD (ppOCD) a distinct subtype? A review of the literature // Behav. Cogn. Psychother. – 2011; 39 (3): 285–310.

  29. Swanson L., Pickett S., Flynn H. et al. Relationships among depression, anxiety, and insomnia symptoms in perinatal women seeking mental health treatment // J. Wom. Health . – 2011; 20 (4): 553–8.

  30. Wenzel A., Haugen E., Jackson L. et al. Anxiety symptoms and disorders at eight weeks postpartum // J. Anxiet. Dis. – 2005; 19 (3): 295–311.

  31. Misri S., Lusskin S., Schultz M. et al. Obsessive-compulsive disorder in pregnant and postpartum women. UpToDate 2011. www.uptodate.com

  32. Buist A. In: Romans SE, Seeman MV Ed. Women’s mental health: a life-cycle approach. Philadelphia, Lippincott Williams & Wilkins 2006; р. 269–82.

  33. Rubinchik S., Kablinger A., Gardner J. Medications for panic disorder and generalized anxiety disorder during pregnancy // Prim. Care Compan. J. Clin. Psychiatry. – 2005; 7 (3): 100–5.

  34. Wenzel A., Haugen E., Jackson L. et al. Prevalence of generalized anxiety at eight weeks postpartum // Arch. Women's Mental Health. – 2003; 6 (1): 43–9.

  35. Teixeira C., Figueiredo B., Conde A. et al. Anxiety and depression during pregnancy in women and men // J. Affect. Dis. – 2009; 119 (1–3): 142–8.

  36. George D., Ladenheim J., Nutt D. Effect of pregnancy on panic attacks // Am. J. Psychiatry. – 1987; 144: 1078–9.

  37. Norcott C., Stein M. Panic disorder in pregnancy // J. Clin. Psychiatry. – 1994; 55: 539–42.

  38. Villeponteaux V., Lydiard R., Laraia M. et al. The effects of pregnancy on preexisting panic disorder // J. Clin. Psychiatry. – 1992; 53: 201–3.

  39. Cohen L., Sichel D., Dimmock J. et al. Impact of pregnancy on panic disorder: a case series // J. Clin. Psychiat. – 1994; 55: 284–92.

  40. Cohen L., Sichel D., Faraone S. et al. Course of panic disorder during pregnancy and the puerperium: a preliminary study // Biol. Psychiatry. – 1996; 39: 950–4.

  41. Wisner K., Peindl K., Hanusa B. Psychiatric episodes in women with young children // J. Affect. Dis. – 1995; 34: 1.

  42. Casiano M., Hawkins D. Major mental illness and childbearing. A role for the consultation-liaison psychiatrist in obstetrics // Psychiat. Clin. North. Am. – 1987; 10 (1): 35–51.

  43. Reynolds J. Post-traumatic stress disorder after childbirth: the phenomenon of traumatic birth // Can. Med. Assoc. J. – 1997; 156: 831–5.

  44. Turton P., Hughes P., Evans C. et al. Incidence, correlates and predictors of post-traumatic stress disorder in the pregnancy after stillbirth // Br. J. Psychiat. – 2001; 178: 556–60.

  45. Vukelić J., Kapamadzija A., Kondić B. Investigation of risk factors for acute stress reaction following induced abortion // Med. Pregl. – 2010; 63 (5–6): 399–403.

  46. Alcorn K., O'Donovan A., Patrick J. et al. A prospective longitudinal study of the prevalence of post-traumatic stress disorder resulting from childbirth events // Psychol. Med. – 2010; 40 (11): 1849–59.

  47. Ford E., Ayers S. Support during birth interacts with prior trauma and birth intervention to predict postnatal post-traumatic stress symptoms // Psychol. Health. – 2011; 1: 1–18.

  48. Chu S., Kim S., Lau J. et al. Maternal obesity and risk of stillbirth: a metaanalysis // Am. J. Obstet. Gynecol. – 2007; 197 (3): 223–8.

  49. Forray A., Mayes L., Magriples U. et al. Prevalence of post-traumatic stress disorder in pregnant women with prior pregnancy complications // J. Matern. Fetal. Neonatal. Med. – 2009; 22 (6): 522–7.

  50. Entringer S., Kumsta R., Hellhammer D. et al. Prenatal exposure to maternal psychosocial stress and HPA axis regulation in young adults // Horm. Behav. – 2009; 55 (2): 292–8.

  51. Fishell A. Depression and Anxiety in Pregnancy // J. Popul. Ther. Clin. Pharmacol. – 2010; 17 (3): 363–9.

  52. Davidson J. Pharmacotherapy of generalized anxiety disorder // J Clin Psychiatry. – 2001; 62 (Suppl. 2): 46–50.

  53. Wang B. Psychiatric Illness during Pregnancy and the Postpartum Period. In: Stern Massachusetts General Hospital Comprehensive Clinical Psychiatry 2008; Ch. 31.

  54. Louik C., Lin A., Werler M. et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects // N. Engl. J. Med. – 2007; 356: 2675.

  55. Nielsen R., Damkier P. Pharmacological treatment of unipolar depression during pregnancy and breast-feeding-a clinical overview // Nord J. Psychiat. – 2012; 66 (3): 159–66.

  56. Hendrick V., Stowe Z., Altshuler L. et al. Placental passage of antidepressant medications // Am. J. Psychiat. – 2003; 160 (5): 993–6.

  57. The Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol №18. Use of antidepressants in nursing mothers. Breastfeed Med 2008; 3: 44–52.

  58. Bar-Oz B., Einarson T., Einarson A. et al. Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors // Clin. Ther. – 2007; 29 (5): 918–26.

  59. Wurst K., Poole C., Ephross S. et al. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies // Birth. Defects. Res. A Clin. Mol. Teratol. – 2010; 88 (3): 159–70.

  60. Nikfar S., Rahimi R., Hendoiee N., Abdollahi M. Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis // Daru. – 2012; 20 (1): 75.

  61. Tuccori M., Montagnani S., Testi A. et al. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update // Postgrad. Med. – 2010; 122 (4): 49–65.

  62. Udechuku A., Nguyen T., Hill R., Szego K. Antidepressants in pregnancy: a systematic review // Aust. N. Z. J. Psychiatry. – 2010; 44 (11): 978–96.

  63. Hemels M., Einarson A., Koren G. et al. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis // Ann. Pharmacother. – 2005; 39 (5): 803–9.

  64. Nakhai-Pour H., Broy P., Bérard A. Use of antidepressants during pregnancy and the risk of spontaneous abortion // CMAJ. – 2010; 182 (10): 1031–7.

  65. Pawar G., Wetzker C., Gjerdingen D. Prevalence of depressive symptoms in the immediate postpartum period // J. Am. Board Fam. Med. – 2011; 24 (3): 258–61.

  66. 't Jong G., Einarson T., Koren G. et al. Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): a systematic review // Reprod. Toxicol. – 2012; 34 (3): 293–7.

  67. Chambers C., Johnson K., Dick L. et al. Birth outcomes in pregnant women taking fluoxetine // N. Engl. J. Med. – 1996; 335: 1010.

  68. Kieler H., Artama M., Engeland A. et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries // BMJ. – 2012; 344: d8012.

  69. Greenough A., Khetriwal B. Pulmonary hypertension in the newborn // Paediatr. Respir. Rev. – 2005; 6: 111–6.

  70. Jensen H., Grøn R., Lidegaard O. et al. The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age. Psychopharmacology (Berl). 2013 Mar 2. Epubю. ahead of print.

  71. Ross L., Grigoriadis S., Mamisashvili L. et al. Selected Pregnancy and Delivery Outcomes After Exposure to Antidepressant Medication: A Systematic Review and Meta-analysis // JAMA Psychiatry. 2013 Feb 27; published online: 1–8.

  72. Jensen H., Grøn R., Lidegaard O. et al. Maternal depression, antidepressant use in pregnancy and Apgar scores in infants // Br. J. Psychiatry. – 2013 Feb. 21. Epub ahead of print.

  73. Howland R. Antidepressant medication and pregnancy: time for randomized controlled trials // J. Psychosoc. Nurs. Ment. Health Serv. – 2013; 51 (2): 11–4.

  74. Greene M. Teratogenicity of SSRIs–serious concern or much ado about little? // N. Engl. J. Med. – 2007; 356 (26): 2732–3.

  75. Bandelow B., Zohar J., Hollander E. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision // W. J. Biol. Psychiatry. – 2008; 9 (4): 248–312.

  76. Källén B., Otterblad O. Antidepressant drugs during pregnancy and infant congenital heart defect // Reprod. Toxicol. – 2006; 21: 221–2.

  77. Antenatal and postnatal mental health: clinical management and service guidance’ (NICE clinical guideline 45) CG45. Is: 2007

  78. Snellen M., Galbally M., Udechuku A. et al. Psychotropic Medication in Pregnancy/Lactation. Revised 2nd Ed. Mercy Health & Aged Care: Melbourne 2007.

  79. American Academy of Pediatrics. Committee on Drugs. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics 2000; 105: 880.

  80. Lusskin S., Misri S. Management of depression in pregnant women. UpToDate 2011. www.uptodate.com

  81. Bellantuono C., Tofani S., Di Sciascio G. et al. Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview // Gen. Hosp. Psychiatry. – 2013; 35 (1): 3–8.

  82. Sarris J., Kavanagh D. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders // J. Altern. Compl. Med. – 2009; 15 (8): 827–36.

  83. Teschke R., Wolff A., Frenzel C. et al. Herbal hepatotoxicity: a tabular compilation of reported cases // Liver Int. – 2012; 32 (10): 1543–56.

  84. Licata A., Macaluso F., Craxì A. Herbal hepatotoxicity: a hidden epidemic // Intern. Emerg. Med. – 2013; 8 (1): 13–22.

  85. Vassiliadis T., Aagnostis P., Patsiaoura K. et al. Valeriana hepatotoxicity // Sleep Med. – 2009; 10 (8): 935.

  86. Mahmoudian A., Rajaei Z., Haghir H. et al. Effects of valerian consumption during pregnancy on cortical volume and the levels of zinc and copper in the brain tissue of mouse fetus // Zhong Xi Yi Jie He Xue Bao. – 2012; 10 (4): 424–9.

  87. Bloniarz J., Zareba S., Rahnama M. Examination of nickel and chromium contents in selected herbs, herbal fruit teas and their infusions // Przegl Lek. – 2004; 61 (Suppl. 3): 58–62.

  88. Caldas E., Machado L. Cadmium, mercury and lead in medicinal herbs in Brazil // Food Chem. Toxicol. – 2004; 42: 599–603.

  89. Raman P., Patino L., Nair M. Evaluation of metal and microbial contamination in botanical supplements // J. Agric. Food Chem. – 2004; 52: 7822–7.

  90. Petty H., Fernando M., Kindzelskii А. et al. Identification of colchicine in placental blood from patients using herbal medicines // Chem. Res. Toxicol. – 2001; 14 (9), 1254–8.

  91. Macías-Peacok B., Pérez-Jackson L., Suárez-Crespo M. et al. Use of medicinal plants during pregnancy // Rev. Med. Inst. Mex. Seguro Soc. – 2009; 47 (3): 331–4.

  92. Mannel M. Drug interactions with St John's wort: Mechanisms and clinical implications // Drug. Saf. – 2004; 27: 773–97.

  93. Jeong T., Park B., Cho J. et al. A prospective study on the safety of herbal medicines, used alone or with conventional medicines // J. Ethnopharmacol. – 2012; 143 (3): 884–8.

  94. Mischoulon D. Update and Critique of Natural Remedies as Antidepressant Treatments // Obstet. Gynecol. Clin. North Am. – 2009; 36 (4): 789–807.

  95. Linde K., Mulrow C., Berner M., Egger M. Review St John's wort for depression // Cochrane Database Syst. Rev. – 2005; (2): CD000448.

  96. Dante G., Pedrielli G., Facchinetti F. et al. Herb remedies during pregnancy: a systematic review of controlled clinical trials // J. Matern. Fetal. Neonatal. Med. – 2013; 26 (3): 306–12.

  97. Решетько О.В., Горшкова Н.В., Луцкевич К.А. и др. Регуляторный статус и проблема безопасности средств растительного происхождения // Ремедиум. – 2010; 5: 30–3.

 

 

 
Рассылка
Важно

→ Фармакопейные статьи


→ Медицинские архивы на службе современного врача


→ Перечень медицинских технологий

ЭКД архив

 

Баннер
Баннер
Баннер
Информационные партнеры:
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер